Pharma Journalist -

AbbVie and Morphic Therapeutic announced that the companies have entered into a research and development collaboration designed to advance a number of Morphic's oral integrin…
Read More...

Daiichi Sankyo Company announced that the first patient has been dosed in a first-in-human phase 1 study assessing the safety and tolerability of DS-1205, a highly selective…
Read More...

AstraZeneca and Merck announced that they were granted orphan drug designation (ODD) by the US Food and Drug Administration (FDA) for Lynparza (olaparib) for the treatment of pancreatic…
Read More...

Endocyte announced that it has entered into an agreement and plan of merger with Novartis AG pursuant to which Novartis will acquire Endocyte for $24 per share, or a total equity value…
Read More...

Iovance Biotherapeutics and MaSTherCell announced that the two companies have entered into a new three-year Manufacturing Services Agreement. MaSTherCell will manufacture TIL for…
Read More...

Hovione announces plan to increase production capacity in oral dosage forms in Portugal, to strengthen the integrated offering. New commercial scale equipment for blending, tableting…
Read More...

IDT Biologika announced that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), an agency of the United States Department of…
Read More...

Foundation Medicine announced a strategic collaboration with Novartis allowing the development of companion diagnostic (CDx) tests for the Novartis portfolio of targeted oncology and…
Read More...

Biogen and Samsung Bioepis announced the European launch of IMRALDI (adalimumab), a biosimilar referencing HUMIRA. Starting today, IMRALDI will begin launching in major markets across…
Read More...

Kala Pharmaceuticals announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for KPI-121 0.25%, a topical product candidate…
Read More...